Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Is BPC 157 Banned? Oral vs. Injectable Forms Explained Akathisia is caused by drug induced dopamine receptor blockade, usually in the striatum. A gut produced peptide called BPC 157 often used for injuries has been recognised to reverse D receptor blockade, and repair dopaminergic Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats Journal of Orthopaedic Surgery and Research Springer Nature Link